22 C
February 21, 2024
The Hona News

Researchers demonstrate that a machine learning model predicts oxaliplatin benefit

The current standard of care for treating patients with stage 3 colon cancer is to use adjuvant therapy with FOLFOX, a combination of the drugs fluorouracil, leucovorin, and oxaliplatin. Although effective, the use of oxaliplatin can lead to known adverse events, mainly neurotoxicity that may be chronic.

Source link

Related posts

Frog embryo study helps scientists unravel the human birth anomaly of intestinal malrotation


Report: US prescription drug prices are 2.78 times those in other wealthy nations


Disorders, diseases associated with childlessness identified


Leave a Comment